High doses of incobotulinumtoxinA for the treatment of post-stroke spasticity: are they safe and effective?

Andrea Santamato; Maurizio Ranieri; Vincenzo Solfrizzi; Madia Lozupone; Michele Vecchio; Antonio Daniele; Antonio Greco; Davide Seripa; Giancarlo Logroscino; Francesco Panza

doi:10.1080/17425255.2016.1198318

High doses of incobotulinumtoxinA for the treatment of post-stroke spasticity: are they safe and effective?

Andrea Santamato
, Maurizio Ranieri
, Vincenzo Solfrizzi
, Madia Lozupone
, Michele Vecchio
, Antonio Daniele
, Antonio Greco
, Davide Seripa
, Giancarlo Logroscino
, Francesco Panza

University of Foggia
University of Bari
Azienda Ospedaliero Universitaria Policlinico "G.Rodolico - San Marco"
IRCCS Ospedale Casa Sollievo della Sofferenza - San Giovanni Rotondo (FG)

Risultato della ricerca: Contributo in rivista › Articolo

5 Citazioni (Scopus)

Abstract

N/A

Lingua originale	Inglese
pagine (da-a)	843-846
Numero di pagine	4
Rivista	Expert Opinion on Drug Metabolism and Toxicology
Volume	12
DOI	https://doi.org/10.1080/17425255.2016.1198318
Stato di pubblicazione	Pubblicato - 2016

Keywords

Botulinum Toxins, Type A
Dose-Response Relationship, Drug
Humans
Muscle Spasticity
Neuromuscular Agents
Pharmacology
Stroke
Toxicology
Upper motor neuron syndrome
adverse effects
botulinum toxin type A
incobotulinumtoxinA
safety
spasticity
stroke

Accesso al documento

10.1080/17425255.2016.1198318

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{658068b0437747f0a0c40b9882b50664,

title = "High doses of incobotulinumtoxinA for the treatment of post-stroke spasticity: are they safe and effective?",

abstract = "N/A",

keywords = "Botulinum Toxins, Type A, Dose-Response Relationship, Drug, Humans, Muscle Spasticity, Neuromuscular Agents, Pharmacology, Stroke, Toxicology, Upper motor neuron syndrome, adverse effects, botulinum toxin type A, incobotulinumtoxinA, safety, spasticity, stroke, Botulinum Toxins, Type A, Dose-Response Relationship, Drug, Humans, Muscle Spasticity, Neuromuscular Agents, Pharmacology, Stroke, Toxicology, Upper motor neuron syndrome, adverse effects, botulinum toxin type A, incobotulinumtoxinA, safety, spasticity, stroke",

author = "Andrea Santamato and Maurizio Ranieri and Vincenzo Solfrizzi and Madia Lozupone and Michele Vecchio and Antonio Daniele and Antonio Greco and Davide Seripa and Giancarlo Logroscino and Francesco Panza",

year = "2016",

doi = "10.1080/17425255.2016.1198318",

language = "English",

volume = "12",

pages = "843--846",

journal = "Expert Opinion on Drug Metabolism and Toxicology",